How to Lower Your Dementia Risk?
Dr. Brad Stanfield examines the conflicting evidence on whether cholesterol-lowering drugs like statins affect dementia risk. He explains that while short-term randomized control trials (RCTs) show no cognitive harm or benefit, observational studies suggest a strong protective effect. The video's focus is a new Mendelian randomization study of over one million people, which helps resolve this paradox by simulating the effects of lifelong medication use through genetics. This new study found that genetic variants mimicking the long-term action of statins and ezetimibe were linked to a massive 76-82% relative risk reduction for dementia, suggesting the protective benefits are long-term and not captured by shorter trials. Dr. Stanfield concludes by highlighting other crucial, modifiable risk factors for dementia, including the importance of treating hearing loss, vision loss, and midlife depression, as well as staying cognitively active.
▶Video · YouTube · Dr Brad StanfieldDementia Rates PLUNGED in Study of 1,091,775 PeopleHere are the links to the research papers referenced in the video: Thumbnail by James Kelly Video edited by Troy Young Script by John Milliken The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of…youtube.com

